U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
107521107521Metabolism of NNK Among African AmericansRecruitingNo Results AvailableLung Cancerhttps://ClinicalTrials.gov/show/NCT01158456
107522107522Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDSCompletedNo Results AvailableHIV+|Fatigue|GoalsBehavioral: Behavioral Activation Therapy|Behavioral: Supportive Counselinghttps://ClinicalTrials.gov/show/NCT01158443
107523107523Acceptance and Commitment Group Therapy (ACT) for Patients With Health AnxietyCompletedNo Results AvailableHypochondriasis|Somatization DisorderBehavioral: ACT group therapyhttps://ClinicalTrials.gov/show/NCT01158430
107524107524Resveratrol in Type2 Diabetes and ObesityActive, not recruitingNo Results AvailableType 2 Diabetes|Obesity|Insulin ResistanceDrug: Placebo|Drug: Resveratrol 40 mg oral three times a day|Drug: Resveratrol 500 mg oral once daily.https://ClinicalTrials.gov/show/NCT01158417
107525107525Notch Inhibitor in Advanced CancerCompletedNo Results AvailableAdvanced CancerDrug: Notch Inhibitorhttps://ClinicalTrials.gov/show/NCT01158404
107526107526Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral FeedingRecruitingNo Results AvailablePremature BirthDevice: NTrainer® Interventionhttps://ClinicalTrials.gov/show/NCT01158391
107527107527Safety and Effectiveness of the Adherus Dural Sealant System When Used as a Dural Sealant in Cranial ProceduresCompletedHas ResultsElective Cranial Procedures With Dural IncisionDevice: Adherus Dural Sealanthttps://ClinicalTrials.gov/show/NCT01158378
107528107528Dermacyd in Odor Reducing.CompletedNo Results AvailableHygieneDrug: LACTIC ACID (Dermacid)|Drug: Glycerine Vegetal Soap Granado Traditionalhttps://ClinicalTrials.gov/show/NCT01158365
107529107529Study to Evaluate the Effect of Short Treatment With Nutritional Supplementation Standardized Innovative Formula, on Growth and Weight Gain in Short and Lean Prepubertal ChildrenCompletedNo Results AvailableGrowth|Low Weight|Low HeightDietary Supplement: Nutritional supplementation formula|Dietary Supplement: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT01158352
107530107530Dare to Move: Treatment of Movement Phobia in Patient With Low Back PainActive, not recruitingNo Results AvailableLow Back PainBehavioral: Arm 2: CBGT-ISE|Behavioral: Arm 1: CBGThttps://ClinicalTrials.gov/show/NCT01158339
107531107531Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And FluCompletedNo Results AvailableCommon Cold|InfluenzaDrug: Resfenol|Other: Placebohttps://ClinicalTrials.gov/show/NCT01158326
107532107532Bedside Screening Method for Patients With Potential Swallowing ImpairmentCompletedNo Results AvailableDeglutition Disorders|DysphagiaDietary Supplement: Thickened supplementhttps://ClinicalTrials.gov/show/NCT01158313
107533107533PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: VEGF inhibitor PTC299https://ClinicalTrials.gov/show/NCT01158300
107534107534Sorafenib. ICORG 06-41, V4CompletedNo Results AvailableEsophageal Cancer|Gastric CancerDrug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01158287
107535107535RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNo Results AvailableAdult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Drug: capecitabine|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01158274
107536107536The Evicel Post-Authorization Surveillance StudyCompletedHas ResultsPeripheral Vascular Disease|HemorrhageBiological: EVICEL â„¢ Fibrin Sealant (Human)https://ClinicalTrials.gov/show/NCT01158261
107537107537Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical CancerRecruitingNo Results AvailableCervical CancerBiological: panitumumab|Drug: cisplatin|Radiation: brachytherapy|Radiation: external beam radiation therapyhttps://ClinicalTrials.gov/show/NCT01158248
107538107538A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)CompletedNo Results AvailableNasal Carriers MRSADrug: LTX-109https://ClinicalTrials.gov/show/NCT01158235
107539107539Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney CancerActive, not recruitingNo Results AvailableClear Cell Renal Cell Carcinoma|Stage IV Renal Cell CancerDrug: sunitinib malate|Other: laboratory biomarker analysis|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: polymorphism analysishttps://ClinicalTrials.gov/show/NCT01158222
107540107540An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in EgyptCompletedNo Results AvailableHuman Papillomavirus InfectionProcedure: Endocervical sampleshttps://ClinicalTrials.gov/show/NCT01158209
107541107541Safety and Efficacy of Infrared Diode Laser on Improvement of Scar and Prevention of Recurrence of Excised KeloidRecruitingNo Results AvailableKeloid|Surgical ScarDevice: infra-red diode laserhttps://ClinicalTrials.gov/show/NCT01158196
107542107542Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosis, Relapsing-RemittingDrug: BAY86-5046_Interferon-beta-1bhttps://ClinicalTrials.gov/show/NCT01158183
107543107543Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)RecruitingNo Results AvailableNon-small Cell Lung CancerRadiation: Prophylactic cranial irradiation|Drug: Erlotinib /Gefitinibhttps://ClinicalTrials.gov/show/NCT01158170
107544107544Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous(VIGIV)CompletedNo Results AvailableSmallpox VaccinationBiological: ACAM2000https://ClinicalTrials.gov/show/NCT01158157
107545107545Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)RecruitingNo Results AvailableNon-small Cell Lung CancerDrug: Endostar|Drug: Paclitaxel/Carboplatinhttps://ClinicalTrials.gov/show/NCT01158144
107546107546Diabetes Prevention in Women With a Recent History of Gestational Diabetes Mellitus (GDM)CompletedNo Results AvailableGestational Diabetes MellitusBehavioral: Balance after Baby Lifestyle Intervention Programhttps://ClinicalTrials.gov/show/NCT01158131
107547107547Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling DonorsActive, not recruitingNo Results AvailableLeukemia, Myeloid, Acute|Myelodysplastic Syndromes|Lymphoma, Non-Hodgkin|Hodgkin Disease|Leukemia, Lymphocytic, Chronic, B-Cell|Multiple MyelomaDrug: Sargramostim|Drug: Plerixaforhttps://ClinicalTrials.gov/show/NCT01158118
107548107548Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)Active, not recruitingNo Results AvailableChronic Graft-versus-host DiseaseDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT01158105
107549107549Trial Comparing Treatment With SInergyâ„¢ System to Conservative Treatment for Chronic Sacroiliac Joint PainTerminatedNo Results AvailableChronic Sacroiliac Joint PainDevice: Treatment with SInergyâ„¢ System|Other: Conservative Treatmenthttps://ClinicalTrials.gov/show/NCT01158092
107550107550Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 TreatmentCompletedNo Results AvailableSolid TumorsDrug: ALN-VSP02https://ClinicalTrials.gov/show/NCT01158079

* Görseller ve İçerik tekif hakkına sahip olabilir